1. Ultrasound in Crystallization
(Blog/blog)

I would be interested to hear about perceptions of ultrasound in crystallization  whether for standard batch crystallization or indeed continuous processing. What are you experiences and opinions?  Have ...

2. Large scale co-crystal approaches
(Blog/blog)

... isolate crystals (often microcrystalline), and (iii) continuous techniques yet to be published but again using ultrasound. Type (ii) methods can also be seen as a continuous processing or in the very least ...

3. Scale-up of co-crystals
(Blog/blog)

... to batch processes, it seemed there could be some mileage in applying this approach to co-crystals. I think ultrasound might help. I would be interested to hear if other people or Prosonix have explored ...

4. Prosonix CEO David Hipkiss talks to in-Pharma
(News/Latest)

... of respiratory medicines.  Please see http://www.in-pharmatechnologist.com/Processing-QC/Prosonix-launches-UMAX-particle-tech-for-respiratory-drugs   For further details of the potential of UMAX® particles in ...

5. Prosonix CEO, David Hipkiss talks to in-Pharma
(News/Newsflash)

... please see the technology article on UMAX® and technology launch news item: Prosonix Announce The Launch Of UMAX technology http://www.in-pharmatechnologist.com/Processing-QC/Prosonix-launches-UMAX-particle-tech-for-respiratory-drugs  ...

6. Prosonix Announce The Launch Of UMAX technology
(News/Latest)

... of mono and combination inhalation therapies independent of delivery platform or device. UMAX® brings together established processing methodologies, such as spray drying and proprietary sonocrystallization ...

7. Prosonix Announce The Launch Of UMAX technology
(News/Newsflash)

... of mono and combination inhalation therapies independent of delivery platform or device. UMAX® brings together established processing methodologies, such as spray drying and proprietary sonocrystallization ...

8. UMAX Pharmaceutical Particle Engineering
(technology/Technology)

... particles whereby two or more pharmaceutical ingredients can be processed into highly crystalline particles. This is particularly beneficial when there is a synergistic action between the multiple drugs, ...

9. Prosonix CEO David Hipkiss talks to CHEManager
(News/Latest)

... Medicines. Within this discussion David spoke at length about the application of proprietary pharmaceutical ultrasonic particle engineering technologies, ultrasonic process chemistry and processing equipment ...

10. Prosonitron
(slider/slider)

Prosonix provide cGMP & ATEX sonocrystallization Prosonitron™ ultrasonic process and reactor technology. They are aligned with emergent FDA “QbD” and “Design for Intent” philosophy. Our proprietary systems ...

11. Particles
(slider/slider)

ProsonitronTM, DISCUS®, SAXTM,  UMAX® SAXTM  and PRT based process technologies are proprietary "Solution-to-Particle" methods for controlling crystal size, shape and polymorph for APIs and helping ...

12. KTP Research Funding For Prosonix and Bath University
(News/Latest)

... to develop methodology and identify new processing technology for the manufacture of pharmaceutical co-crystals and binary API crystals suitable for use in inhaled and oral medicines.  The primary ...

13. Download Prosonix pdf
(About us/about us)

... for better medicines and Part 3 informs you about how we use our process engineering skills to turn innovative ideas into truly commercial technology and structured pharamceutical products:      ...

14. Prosonix and Syrris launch SonoLab
(News/Latest)

... scale sonocrystallization and sonoprocessing equipment, the two companies are pleased to announce the launch of the proprietary  ...

15. SonoLab
(technology/Technology)

... with novel transducer based design, allows reproducible control of crystallization processes, enabling selectivity of parameters such as particle size, shape, crystallinity and polymorphism. The Atlas ...

16. FDA Quality by Design
(Pharmaceuticals/Pharmaceuticals)

... of how the API (Active Pharmaceutical Ingredient) attributes and manufacturing process relate to its performance should be sought. New Chemical Entities (NCE) are selected by considering clinical efficacy, ...

17. Ultrasonic Particle Rounding
(technology/Technology)

Ultrasonic Particle Rounding Technology (PRT) is exclusively in-licensed to Prosonix (US 6669122). Used in combination, this process technology and the proven Prosonix ProsonitronTM process and reactor ...

18. Particle Engineering
(Pharmaceuticals/Pharmaceuticals)

... and crystal engineering processes. Prosonix achieve this through the selective application of power ultrasound, via patented particle engineering and crystallization technologies, such as SAX, DISCUS and ...

19. DISCUS: Dispersive Crystallization with Ultrasound for Manufacture of Mesoscopic Particles
(technology/Technology)

Antisolvent precipitation is an indispensable tool for the process chemist: Often crystallisation can be achieved by mixing a solution of the drug substance to be crystallised with an antisolvent, so that ...

20. Combination Therapy
(Pharmaceuticals/Pharmaceuticals)

With SAXTM we have designed Combination Particles with every intention of manufacturing them for a brand new way to treat Asthma/COPD. The process virtually eliminates the variability associated with blending ...